ANTIBACTERIAL TREATMENT OF ACUTE BACTERIAL DISEASES OF THE UPPER RESPIRATORY TRACT IN CHILDREN

Аннотация

In acute respiratory viral infections (ARVI) in children, antibacterial therapy is required in only 6-8% of cases accompanied by bacterial complications. This article discusses only lesions of the upper respiratory tract and some types of bronchitis (caused by mycoplasma and chlamydia), for which the use of antibacterial agents is indicated. Unfortunately, the frequency of prescribing antimicrobial drugs to children with ARVI significantly exceeds this figure, reaching 65-85% in outpatient clinics and 98% in hospitals, with antibacterial agents administered parenterally in more than 40% of outpatient clinics and 70% in hospitals [1,2]. With this approach, there are 39 injections per inpatient with uncomplicated ARVI (laryngitis, bronchitis), and 74 per patient with acute pneumonia.